These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31210663)

  • 21. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
    Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Sahani DV; Pergolini I; Negreros-Osuna AA; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.
    Aronsson L; Andersson R; Ansari D
    Scand J Gastroenterol; 2017 Aug; 52(8):803-815. PubMed ID: 28446039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor.
    Schiavo Lena M; Cangi MG; Pecciarini L; Francaviglia I; Grassini G; Maire R; Partelli S; Falconi M; Perren A; Doglioni C
    Virchows Arch; 2021 Jun; 478(6):1215-1219. PubMed ID: 33005981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
    Stotz M; Eisner F; Szkandera J; Absenger G; Kornprat P; Lackner C; Samonigg H; Gerger A; Pichler M
    J Clin Pathol; 2013 Sep; 66(9):753-7. PubMed ID: 23750038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms.
    Koh YX; Zheng HL; Chok AY; Tan CS; Wyone W; Lim TK; Tan DM; Goh BK
    Surgery; 2015 Mar; 157(3):496-509. PubMed ID: 25656693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?
    Bassi C; Crippa S; Salvia R
    Gut; 2008 Mar; 57(3):287-9. PubMed ID: 18268051
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
    Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
    J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical management of intraductal papillary mucinous neoplasm].
    Kim YT
    Korean J Gastroenterol; 2008 Oct; 52(4):214-9. PubMed ID: 19077522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathological features and long term outcome related to histopathological group.
    De Moor V; Arvanitakis M; Nagy N; Coppens E; Delhaye M; Closset J
    Hepatogastroenterology; 2012; 59(114):565-9. PubMed ID: 22353525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating neutrophils in pancreatic neoplasia.
    Reid MD; Basturk O; Thirabanjasak D; Hruban RH; Klimstra DS; Bagci P; Altinel D; Adsay V
    Mod Pathol; 2011 Dec; 24(12):1612-9. PubMed ID: 21822201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive mucinous cystic neoplasms of the pancreas.
    Baker ML; Seeley ES; Pai R; Suriawinata AA; Mino-Kenudson M; Zamboni G; Klöppel G; Longnecker DS
    Exp Mol Pathol; 2012 Dec; 93(3):345-9. PubMed ID: 22902940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis.
    Brunetti O; Aprile G; Marchetti P; Vasile E; Casadei Gardini A; Scartozzi M; Barni S; Delfanti S; De Vita F; Di Costanzo F; Milella M; Cella CA; Berardi R; Cataldo I; Scarpa A; Basile D; Mazzuca F; Graziano G; Argentiero A; Santini D; Reni M; Cascinu S; Silvestris N
    Pancreas; 2018 Jul; 47(6):759-771. PubMed ID: 29771769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.